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Background: Environmental effects and personal experiences could be expressed in
individuals through epigenetic non-structural changes such as DNA methylation. This
methylation could up- regulate or down-regulate corresponding gene expressions and
modify related phenotypes. DNA methylation increases with aging and could be related
to the late expression of some forms of mental disease. The objective of this study
was to evaluate the association between anxiety disorders and/or depression in older
women and DNA methylation for four genes related to anxiety or depression.
Methods: Women aged 65 and older with (n = 19) or without (n = 24) anxiety disorders
and/or major depressive episode (DSM-IV), were recruited. DNA methylation and single
nucleotide variant (SNV) were evaluated from saliva, respectively by pyrosequencing
and by PCR, for the following genes: brain-derived neurotrophic factor (BDNF; rs6265),
oxytocin receptor (OXTR; rs53576), serotonin transporter (SLC6A4; rs25531), and
apolipoprotein E (APOE; rs429358 and rs7412).
Results: A greater BDNF DNA methylation was observed in subjects with
anxiety/depression compared to control group subjects (Mean: 2.92 SD ± 0.74 vs.
2.34 ± 0.42; p = 0.0026). This difference was more pronounced in subjects carrying
the BDNF rs6265 CT genotype (2.99 ± 0.41 vs. 2.27 ± 0.26; p = 0.0006) than
those carrying the CC genotype (p = 0.0332); no subjects with the TT genotype
were observed. For OXTR, a greater DNA methylation was observed in subjects with
anxiety/depression, but only for those carrying the AA genotype of the OXTR rs53576
SNV, more particularly at one out of the seven CpGs studied (7.01 ± 0.94 vs. 4.44 ±
1.11; p = 0.0063). No significant differences were observed for APOE and SLC6A4.
Conclusion: These results suggest that DNA methylation in interaction with SNV
variations in BDNF and OXTR, are associated with the occurrence of anxiety/depression
in older women.
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Introduction
It is well-known that many mental diseases include a signiﬁcant
hereditary component. For instance, the heritability of anxiety
disorders and depression, which are among the most prevalent
and costly psychiatric disorders (Rice and Miller, 1998; Kessler
et al., 2005; Olesen et al., 2012), is estimated at between 20 and
40% (Scherrer et al., 2000; Sullivan et al., 2000; Hettema et al.,
2001; Kendler et al., 2001). Children of individuals with anxiety
disorders show a signiﬁcant increase risk (4–6 times more) of
developing the same anxiety disorder as their parents in contrast
to children without aﬀected parents. Therefore the major source
of this familial risk is genetic, at least according to the greater co-
occurrence of anxiety disorders in identical monozygotic twins
compared to non-identical dizygotic twins (Hettema et al., 2001).
And, ﬁnally, anxiety disorders and depressive disorders are highly
comorbid (Beekman et al., 2000; Kessler et al., 2003, 2010), and
previous results suggest a notable mutual genetic origin (Neale
and Kendler, 1995; Roy et al., 1995).
In contrast with autosomal dominant genetic disorder, such as
Huntington’s disease where defect of a single gene is responsible
of the pathology, anxiety disorders and depression are viewed as
complex traits. They include a hereditary portion with multiple
genetic anomalies within several diﬀerent genes interacting
together, as well as with environmental factors. Among genes
involved in anxiety and depression, the gene which has received
most attention is probably the serotonin transporter (SLC6A4
previously 5-HTT). SLC6A4 promotor showed a well-studied
length polymorphism (5-HTTLPR) with a short or a long form.
The short form has been associated with a reduced transcriptional
eﬃciency of SLC6A4, resulting in decrease SLC6A4 expression
and serotonin reuptake compared to the long form (Lesch et al.,
1996; Gerretsen and Pollock, 2008). The short form has also been
associated with the presence of social phobia (Furmark et al.,
2004), obsessive-compulsive disorder (Hasler et al., 2006), post-
traumatic stress disorder and depression (Kilpatrick et al., 2007),
and with anxiety-related traits such as neuroticism and danger
avoidance (Lesch et al., 1996). However, a meta-analysis did not
conﬁrm the association of the short form with depression (Risch
et al., 2009).
Among other genes, the brain-derived neurotrophic factor
(BDNF) has been associated with major depression (Verhagen
et al., 2010; Pei et al., 2012) and with neuroticism (Frustaci
et al., 2008). Lower BDNF level was observed in individuals
with depression (Brunoni et al., 2008) and in post-mortem
brain of suicide victims with major depression (40%) or other
psychiatric disorders (Dwivedi et al., 2003; Karege et al., 2005).
Moreover, a higher level of BDNF has been observed in those
Alzheimer’s patients showing symptoms of depression compared
to those with no depressive symptoms (Hall et al., 2011). Data
from individuals with depression suggest that a substitution
from valine to methionine, at amino-acid position 66 (BDNF
Val66Met), could be responsible for structural alterations in
the hippocampus and the prefrontal cortex (Cardoner et al.,
2013) and in the uncinate fasciculus, a ﬁber tract linking
these two regions (Carballedo et al., 2012). It has been
proposed that these neural alterations in patients with depression,
could result in poorer treatment outcomes (Cardoner et al.,
2013).
The oxytocin receptor (OXTR) is another gene that appears
to be a factor in the etiology of anxiety and depression.
The haplotype GGGTGTC of the SNVs OXTR rs11131149,
rs2243370, rs2243369, rs13316193, rs2254298, rs2268493,
and rs2268491 was associated with depressive temperament
(Kawamura et al., 2010), while in female adolescents, with
adverse parental environment, anxiety and depressive symptoms
were the most severe in those heterozygous for OXTR rs2254298
(Thompson et al., 2011). It was also shown that carriers of the
GG and AG genotypes of the SNV OXTR rs53576 may present a
greater biological sensitivity as well as stress reactivity in terms of
environmental adaptation (Chang et al., 2014).
Finally, the apolipoprotein E (APOE) is a well-studied gene
in geriatric psychiatry with three major forms of APOE resulting
from the combination of two functional SNVs changing the
protein amino acids, and named: APOE2 (Cys112, Cys 158),
APOE3 (Cys112, Arg158), and APOE4 (Arg112, Arg158; Mahley
and Rall, 2000). APOE3 is the most frequent one and is observed
in about 78% of the population, while APOE2 and APOE4 are
observed in about 6 and 17% of the population, respectively
(Eisenberg et al., 2010). Unlike APOE2 and APOE3, APOE4
increases the risk of Alzheimer’s diseases (Poirier et al., 1993)
and vascular dementia associated with a higher risk of cognitive
decline (Lavretsky et al., 2003; Corsentino et al., 2009; Niti
et al., 2009). Additionally it has been proposed that APOE is
implicated in anxiety (Raber, 2007; Siegel et al., 2012), but data
in humans on this topic are scarce. Data on female mice indicate
that the females with APOE4 allele had higher anxiety level
than the carriers of the APO2 and APOE3 alleles (Siegel et al.,
2012).
DNA methylation is the main studied epigenetic factor
modulating gene eﬀects. Following an environmental stimulus,
a methyl group could be added by methylase enzymes to
the cytosine (C), located just before a guanine (G) in CpG
DNA regions. This could be reversed by demethylase enzymes
and/or be heritably transmitted to descents. It was observed
that with aging some DNA regions rich in CpG become
hypermethylated, whereas those DNA regions poor in CpG
could become hypomethylated (Heyn et al., 2012). For instance,
variations in methylation showed a strong correlation with brain
chronological age (Hernandez et al., 2011). Epigenetic changes
by DNA methylation are generally associated with changes in
gene expression, as where a greater percentage of methylation is
associated with a lower gene expression, and vice-versa. An age-
related loss of methylation can be explained by reduced ﬁdelity
of the maintenance methyltransferase DNMT1, whereas an age-
related increase in methylation could potentially reﬂect the
accumulation of stochastic methylation events (Christensen et al.,
2009). A pangenomic analysis of age-related changes in DNA
methylation showed that the DNA regions diﬀerently methylated
with aging are generally associated with structural variants such
as SNVs (Bell et al., 2012). It has been suggested that individuals
living older than 85, and who had not developed major age-
related diseases, carry more genetic or epigenetic resistant factors
to sickness that attenuate the eﬀects of disease susceptibility
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factors (Halaschek-Wiener et al., 2009). This was conﬁrmed in
healthy centenarians where the number of protective variants
was higher than the number of genetic variants associated with
diseases similar to those observed in the general population
(Sebastiani and Perls, 2012).
Presently, data on combined genetic and epigenetic of
complex traits in older adults are scarce even more for anxiety or
depression disorders. One example is the obervation of an age-
dependent. allele-speciﬁc methylation wherein young individuals
(20–30 years) the diﬀerence in DNA methylation between alleles
is signiﬁcant, whereas in individuals older than 60 years it is not
detectable (Stepanow et al., 2011). Moreover, the allele showing a
decrease in methylation status was associated with an increasing
body mass index and with an allele-speciﬁc transcription of
the corresponding gene (Stepanow et al., 2011). In a similar
approach, the objective of the present study was to evaluate, in
a sample of older women, the association of anxiety disorders
and/or depression with a speciﬁc DNA methylation according
to SNVs in four candidate genes: SLC6A4, BDNF, OXTR, and
APOE.
Materials and Methods
ESA Study
Participants come from the ESA Study (Enquête sur la Santé
des Aînés; Survey on Elders’ Health), a population-based study
conducted from 2005 to 2008. The ESA Study comprises
a random sample of 2811 community dwellings inhabited
by French-speaking adults aged 65 years or older, living in
the province of Québec, Canada (Préville et al., 2008). A
random dialing method with a stratiﬁcation of proportional
sample of households was used, according to geographical areas
(metropolitan, urban, and rural) and the 16 administrative
regions of the province of Québec. A random sampling
method was also used to select only one participant within the
household.
Data were collected by experienced research nurses through
two in-home structured interviews, separated by ∼12 months
(mean = 12.5; SD = 1.4). Collected data included the French
version of the Mini-Mental State Examination (Hébert et al.,
1992) and the presence of DSM-IV (American Psychiatric
Association, 2000) anxiety disorders (generalized anxiety
disorder, panic disorder/agoraphobia, speciﬁc, phobia, and
social phobia), major depressive episode and minor depression
through adapted sections of the Diagnostic Interview Schedule
and Composite International Diagnostic Interview (Robins et al.,
1981; Erdman et al., 1992). The presence of anxiety disorders and
depression were measured for a period of 12 months preceding
each interview. Interviews were completed only with participants
who scored 22 or higher on the MMSE (26 participants had
a MMSE score < 22 at baseline). The research procedures of
the ESA Study were previously reviewed and authorized by the
ethics committee of the Institut Universitaire de Gériatrie de
Sherbrooke. At the beginning of the interview, the participant
was asked for his consent in writing to participate in the
study.
Study Sample
From the ESA Study sample, we aimed to recruit approximately
20 women who met DSM-IV criteria for anxiety disorder and/or
depression in, at least, one interview and, another 20 women
without anxiety or depression at both interviews, as a control
group. Those with medical history of psychosis or schizophrenia
were excluded. ESA participants were contacted by phone in
2010 and invited to participate in the present genetic study.
Nineteen participants with previous anxiety disorder and/or
depression and 24 participants without anxiety or depression
(control group), were recruited. Each participant received a saliva
self-sample kit (Oragene-RNA; DNA Genotek) by mail, which
he had to ﬁll according to included instructions. Instructions
speciﬁed that the participants should not drink anything, except
water, and should not have eaten or smoked 1 h before sampling.
The saliva samples were mailed back to us through regular mail.
Upon reception, samples were heated 1 h at 50◦C and kept at
room temperature until being processed within the following
week. The present project was reviewed by the ethics committee
of the Institut Universitaire en Santé Mentale de Québec and all
participants in the study gave their written consent.
Genetic Analyses
DNA was extracted using Qiagen columns (DNA mini kit) with
a Qiacube robot (Qiagen). DNA concentrations were estimated
using an intercaling ﬂuorescent dye (Qubit), after what, DNA
samples were kept at −20◦C until their analyses. Targeted genes
and SNVs included the apolipoprotein E (APOE) with SNVs
rs429358 and rs7412, the brain derived neuropeptide factor
(BDNF; rs6265), the oxytocin receptor (OXTR; rs53576) and
the serotonin transporter (SLC6A4 previously named 5-HTT;
5-HTTLPR and rs25531). Selection of SNVs was made on the
base of their functionality altering the functions of their encoded
peptide or the expression of the gene. Except for the intronic
OXTR rs53575, which was chosen because of previous association
with stress reactivity (Chang et al., 2014). Genotyping of SNVs
was done on a real time PCR (Lightcycler 480; Roche) using
speciﬁc 5′ nuclease TaqMan assays (proprietary sequences; Life
Technologies; see Table 1 for the speciﬁc assay used). For all
SNVs, PCR was made using 0.5 ul of 10X PCR Master Mix
(Roche), 0.25 ul 40X TaqMan assay, 50 ng DNA in a ﬁnal
volume of 5 ul. PCR run included a denaturing step of 10 min
95◦C followed by 35 PCR cycles (1 min 95◦C, 1 min 55◦C,
1 min 72◦C). Length fragment polymorphism of SLC6A4 (5-
HTTLPR) was determined by a speciﬁc PCR (Lotrich et al.,
2008) to which was added the analysis of rs25531 (A/G; Hu
et al., 2006) by MspI restriction fragment length analysis. Two
non-polymorphic MspI restriction sites will cut to 312 and
356 nucleotides, respectively the 499 and 539 initial DNA
fragments, that will be reduced further to 180 nucleotides in
the presence of the G allele of rs25531. DNA fragments were
detected by a gel electrophoresis analysis (DNA sequencer;
LiCor). DNA methylation analysis was done by pyrosequencing
(Pyromark 96, Qiagen) using proprietary sequences Qiagen kits
(see Table 2), except for APOE for which pooled DNA was
analyzed on Illumina Beadchips. DNA bisulﬁte treatment was
done following manufacturer instructions (EpiTect kit; Qiagen).
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TABLE 1 | Allele frequencies for gene variants in participants with and without anxiety/depression.
Genes Variants Group Alleles p1
SLC6A4 Short S/Long L
rs25531 (A/G)
Sa 312 La 356 Lg 180
Anxiety/depression 0.3421 (N = 13) 0.5526 (N = 21) 0.1053 (N = 4) 0.1601
Control 0.4792 (N = 23) 0.5000 (N = 24) 0.0208 (N = 1)
OXTR rs53576 (G/A)
Assay# C_3290335_10
G A
Anxiety/depression 0.6053 (N = 23) 0.3947 (N = 15) 0.9744
Control 0.6087 (N = 28) 0.3913 (N = 18)
BDNF rs6265 (C/T; Val66Met)
Assay# C_11592758_10
C T
Anxiety/depression 0.7667 (N = 23) 0.2333 (N = 7) 0.8897
Control 0.7778 (N = 28) 0.2222 (N = 8)
APOE∗ rs7412 (C/T; Cys112Arg)
Assay# C_904973_10
rs429358 (C/T; Cys158Arg)
Assay# C_3084793_20
APOE2 (TT) APOE3 (TC) APOE4 (CC)
Anxiety/depression 0.0833 (N = 3) 0.8333 (N = 30) 0.0833 (N = 3) 0.6785
Control 0.0833 (N = 4) 0.7708 (N = 37) 0.1458 (N = 7)
Assay numbers (Life Technologies) are indicated when appropriate. ∗One anxiety subject and one control are heterozygotes CT/CT for both SNPs and their diplotype (TT,
TC, or CC) could not be determined.
1p-value from chi-square test.
Number of alleles observed per group are indicated between parentheses.
After puriﬁcation, concentration of bisulﬁte treated DNA was
reevaluated (Qubit).
Statistical Analyses
Allele frequencies between aﬀected and non-aﬀected groups
for all four targeted genes were compared using a chi-square
test. Because the number of subjects is small in each group,
allele frequencies should be taken with caution, thus very
large diﬀerences in frequencies between the two groups are
necessary to detect statistically signiﬁcant results. The homo- or
heteroscedasticity of the results has been tested using a F-test
and two-tailed t-tests, adjusted accordingly, were used to evaluate
diﬀerences between groups for mean percentages of methylation.
It was shown that relatively small diﬀerences in methylation
could provide statistically signiﬁcant results. For example, a
methylation value of 0.75 SD 0.04 observed in females, being
signiﬁcantly diﬀerent in males (0.79 SD 0.04; p = 9.23e-06;
Boks et al., 2009). Since the relatively small size of our sample,
a Wilcoxon–MannWhitney test (SAS) was also applied. Alpha
level was corrected for multiple testing according to the number
of candidate genes for chi-square tests (0.05/4; adjusted p-value
0.0125), and to the number of methylation regions for the t-tests
(0.05/10; adjusted p-value 0.005).
Results
All 19 participants with depression had a concurrent anxiety
disorder, except for one who had a major depressive disorder
alone. Participants with anxiety disorder/depression did not
diﬀer from the control group (N = 24) according to age (mean:
70.7, SD: 5.6; control group: 72.8, 4.5; p = 0.200), and MMSE
score results (mean: 29.4, SD: 0.8; control group: 29.1, 1.2;
p = 0.374).
Figure 1 presents the SNVs analyzed and their location in
the four targeted genes of the study. For BDNF and APOE,
SNVs are within coding sequences and are functional variants
changing corresponding amino acids, while SLC6A4 is located in
the promotor region and change level of its expression. OXTR is
located in an intron and its direct eﬀect on RNA or protein is not
known. Table 1 presents the genotyping results. No signiﬁcant
diﬀerences between the two groups were observed.
Figure 1 also showed the location of the diﬀerent DNA regions
of the genes analyzed for their methylation. Table 2 shows the
mean methylation percentages by DNA region tested. Overall,
BDNF was analyzed for seven DNA regions over 30 CpGs (3–6
CpGs per region), OXTR for two regions with nine CpGs (four
and ﬁve CpGs, respectively), APOE for one region with four
CpGs and SLC6A4 for one region with six CpGs. For BDNF, the
percentage of methylation in one region was signiﬁcantly higher
in participants with anxiety/depression compared to control
participants (t-test p = 0.0026; Wilcoxon–MannWhitney test
p = 0.0001). Signiﬁcant or marginally signiﬁcant diﬀerences
were also observed individually for all three CpGs included in
this region (t-test p = 0.0439, 0.0022, and 0.0483, respectively).
Moreover, this association was greater in participants with
anxiety/depression carrying the CT genotype of the SNV rs6265
than in control group participants (2.99 ± 0.41 N = 7 vs.
2.27 ± 0.26 N = 8; t-test p = 0.0006; Wilcoxon–MannWhitney
test p = 0.0065), while remaining marginally signiﬁcant in
participants with anxiety/depression carrying the CC genotype
(2.89 ± 0.89 N = 12 vs. 2.36 ± 0.51 N = 15; t-test p = 0.0332;
Wilcoxon–MannWhitney test p = 0.0067). No subjects carrying
the TT genotype was detected in our sample.
The OXTR gene showed a higher methylation in the
anxiety/depression group, but only when subjects were stratiﬁed
by SNV rs53576 genotypes. Compared to the control group,
only carriers of the AA genotype showed a higher percentage
of methylation (near twice) in anxiety/depression participants
(8.02 ± 2.66 N = 5 vs. 4.78 ± 1.12 N = 3; p = 0.0490) while no
signiﬁcant diﬀerences was observed for the two other genotypes
AG (5.63 ± 2.59 N = 5 vs. 5.69 ± 2.20 N = 12; p = 0.4810)
and GG (5.93 ± 1.77 N = 9 vs. 6.09 ± 1.31 N = 8, p = 0.4197;
Table 2B). The signiﬁcant diﬀerence observed came mainly from
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TABLE 2 | Percentages of methylation among different genes forparticipants with and without anxiety/depression.
(A) Per DNA assays and CpGs.
Gene (PyroMark CpG assay) DNA #assay #CpGs Anxiety/depression
(mean ± SD) N = 19
Control
(mean ± SD) N = 22
p1
BDNF (Hs_BDNF_#_PM) 01 3 3.50 ± 0.85 3.19 ± 0.81 0.1158∗
02 3 2.92 ± 0.74 2.34 ± 0.42 0.0026∗∗
03 6 4.88 ± 0.67 5.26 ± 2.17 0.2232
04 6 9.93 ± 6.47 8.25 ± 1.66 0.1414
06 3 5.32 ± 1.23 5.08 ± 1.05 0.2414
08 4 4.36 ± 2.55 3.58 ± 1.03 0.1220
10 5 8.94 ± 2.55 9.44 ± 2.73 0.2747
OXTR (Hs_OXTR_#_PM) 01 4 6.40 ± 2.34 5.71 ± 2.82 0.1425∗∗∗
02 5 27.45 ± 6.06 25.39 ± 8.90 0.1992
APOE (na) 01 4 0.35 ± 0.09 0.32 ± 0.10 na
SLC6A4 (Hs_SLC6A4_#_PM) 01 6 4.72 ± 0.98 4.61 ± 0.86 0.3510
∗One CpG is marginally significant p = 0.0517.
∗∗Wilcoxon–MannWhitney test: p < 0.0001.
∗∗∗A significant difference is observed when stratifying subjects according to the SNV rs53576 (see Table 2B).
1p-value resulting from t-tests.
(B) Per SNPs and genotypes.
Gene (SNP) Genotypes Anxiety/depression
(mean ± SD)
Control (mean ± SD) p
BDNF (rs6265 (C/T; Val66Met)
DNA assay_02
CC 2.89 ± 0.89 N = 12 2.36 ± 0.51 N = 15 0.0332∗
CT 2.99 ± 0.41 N = 7 2.27 ± 0.26 N = 8 0.0006∗∗
TT Na Na Na
OXTR (rs53576 G/A)
DNA assay_01
GG 5.93 ± 1.77 N = 9 6.09 ± 1.31 N = 8 0.4197
GA 5.63 ± 2.59 N = 5 5.69 ± 2.20 N = 12 0.4810
AA 8.02 ± 2.66 N = 5 4.78 ± 1.12 N = 3 0.0490
OXTR (rs53576 G/A)
DNA assay 01, CpG_2
GG 5.96 ± 1.47 N = 9 6.16 ± 1.33 N = 8 0.3851
GA 5.69 ± 0.92 N = 5 5.56 ± 1.63 N = 12 0.4359
AA 7.01 ± 0.94 N = 5 4.44 ± 1.11 N = 3 0.0063
Only those results from genes showing some differences are reported.
∗Wilcoxon–MannWhitney test: p = 0.0067.
∗∗Wilcoxon–MannWhitney test: p = 0.0065.
Nominally significant p values are in bold.
CpG 2 of the four CpGs contained in this region (7.01 ± 0.94
vs. 4.44 ± 1.11; p = 0.0063; Table 2B), the other three CpGs
giving non-signiﬁcant results (0.06 < p < 0.10). However, the
OXTR results became non-signiﬁcant when using the Wilcoxon–
MannWhitney test. APOE did not show great diﬀerences when
compared over all four CpGs (Table 2), while no association was
observed for the gene SLC6A4.
Discussion
The objectives of the present study were to verify whether older
women with anxiety disorder/depression diﬀer from control
subjects according to DNA methylation and genotypes at SNVs
in BDNF, OXTR, SLC6A4, and APOE. The results indicated
that older women with anxiety disorders/depression diﬀered on
BDNF DNA methylation level from the women in the control
group, particularly for the CT carriers. Moreover, the higher DNA
methylation in BDNF CT genotype carriers was conﬁrmed in a
second group of women with anxiety/depression disorders and
healthy controls (3.36 ± 0.15 N = 4 vs. 2.93 ± 0.08 N = 4;
t-test p = 0.0022), while CC and TT carriers (N = 4 each)
showed no signiﬁcant diﬀerences. On the other hand, groups
also diﬀered on OXTR DNA methylation level, but this eﬀect
was dependent to speciﬁc OXTR SNVs and disappeared on the
Wilcoxon–MannWhitney test.
Previous results suggested that a lower level of BDNF
expression is associated with depression (Groves, 2007). This was
observed in human with depression (Marvanova et al., 2001;
Karege et al., 2002, 2005; Dwivedi et al., 2003; Aydemir et al.,
2005) as well as in a mice model of depression (Tsankova et al.,
2006). In this study we observed a higher methylation of BDNF
in older women with anxiety disorders/depression. Traditionally,
DNA methylation has been thought of as being involved in
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FIGURE 1 | Exon (full squares) and intron (lines) structure of BDNF (A),
OXTR (B), SLC6A4 (C), and Apoe (D) genes of the study, and of their
different isoforms produced by differential splicing. The location of the
methylation regions (red square) and of the SNV (blue dot) are indicated where
vertical lines indicate an exonic location. Exon are identified where roman letter.
Adapted form NCBI database.
gene silencing, even if research in recent years has shown a
more complex picture (Muers, 2013). One to 10% diﬀerences
in methylation were reported to be signiﬁcantly associated
to gene expression (Gervin et al., 2012). We would need to
evaluate BDNF RNA expression to conﬁrm this possibility. If
so, we will have to take into account the isoforms of BDNF
as shown in mice results where only two of the ﬁve BDNF
isoforms tested showed a diﬀerent expression in depressive
mice (Tsankova et al., 2006). In human, BDNF showed a
high number of isoforms (see Figure 1) that could be highly
regulated in their expression according to biological (tissue, age,
sex) or environmental (stress, pollution, nutrition, medication)
factors. Moreover, these isoforms could have signiﬁcant diﬀerent
phenotypical properties that could be opposite in eﬀect.
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For example, the short transcript form of the BCL-X gene
promotes apoptosis, while the long form inhibits cell death (Boise
et al., 1993).
DNA methylation is naturally greater in CpG rich islands
of older persons (Horvath, 2013). Since we compared subjects
with anxiety-disorders/depression to control group subjects of
the same age group, higher DNA methylation in subjects with
anxiety disorders/depression did not come from aging per se.
Similarly, sex, comorbidities and ethnicity did not come into play
since all individuals were female of caucasian origins with no
other obvious disease.
The OXTR gene has been less studied in relation to
anxiety/depression. One study indicated an association between
the GG genotype of the SNV rs53576 with higher levels of
adult separation anxiety (Costa et al., 2009). We observed in
older adults a possible higher DNA methylation in the anxiety
disorders/depression group for carriers of the AA genotype
compared to the control group. This ﬁnding contrasts with
previous results showing an association between anxiety and GG
genotype in younger adults. A higher DNA methylation of AA
subjects is probably associated with a lower OXTR expression.
We can hypothesize that for OXTR the eﬀects of the diﬀerent
genotypes of SNV rs53576 varied according to age (adolescent
vs. young adult vs. old adults), as observed previously with body
mass index (Stepanow et al., 2011), since etiologies of mental
diseases may diﬀer between old and young adults. Previous
results indicated a diﬀerent genetic inﬂuence between young
and old adults on neuropathological manifestations associated
with depression (Taylor et al., 2005). Genetic predispositions to
mental diseases are modulated by environmental factors and
their eﬀects could cumulate through aging by the addition of
stressful events endured during life (Lupien et al., 2005). Previous
studies observed an association between the BDNF Met allele
in older adults (Pei et al., 2012), but not in younger adults
(Verhagen et al., 2010), and it was proposed that a decreased
activity in the BDNF system may have a stronger eﬀect in
older adults (Pei et al., 2012). Similarly, the short form of 5-
HTTLPR polymorphism of SLC6A4 was associated with reduced
hippocampal volume in older adults with early onset depression
(at a younger age) whereas the long form was associated with
reduce hippocampal volume in older adults with late-onset
depression (Taylor et al., 2005). For instance, depression arising
at an advanced age could be due to prodromal Alzheimer’s disease
(Panza et al., 2010), cerebrovascular pathology (Alexopoulos
et al., 1997; Alexopoulos, 2006), or subcortical Lewy bodies
(Tsopelas et al., 2011).
The present study is one of a few to examine DNAmethylation
in older adults with anxiety disorders/depression. The results
have to be interpreted in light of some limitations. First,
the epigenetic measures were obtained from peripheral tissue
(saliva), which raises the problem of brain concordance of
the results. Although imperfect, it is now recognized that
peripheral tissues such as blood or saliva (Horvath et al.,
2012; Thompson et al., 2013) could be good surrogates
for brain tissue when studying DNA methylation or RNA
expression. Secondly, saliva was not sampled at the same
time that mental health evaluation was done. Therefore, it
is possible that the DNA methylation level did not reﬂect
exactly the initial anxiety/depressive symptoms. And ﬁnally,
the present sample is relatively modest and future studies
using larger samples would be required to conﬁrm our
ﬁndings.
These preliminary results suggest that genetic (SNV) and
epigenetic (DNA methylation) factors interactions in BDNF
and eventually in OXTR genes are involved in the anxiety
disorders/depression phenotype in older adults. However, it is
expected that these two genes alone do not explain all cases of
anxiety disorders/depression in older women, and that additional
genes could be involved. Overall, the present preliminary ﬁndings
need to be conﬁrmed in women, and men should also be
investigated in future studies.
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